Trial Profile
Insulin Glargine Plus Insulin Glulisine MDI Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2) Evaluating Differences in Patient Reported Outcomes.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Insulin glulisine (Primary) ; Insulin aspart/insulin protamine aspart; Insulin neutral protamine lispro/insulin lispro
- Indications Diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sanofi
- 29 Jun 2010 Results have been presented at the 70th Annual Scientific Sessions of the American Diabetes Association.
- 26 Jun 2010 Results reported in two abstracts at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA), according to a sanofi aventis media release.
- 08 Apr 2009 Trial phase changed from IV to III as reported by ClinicalTrials.gov.